Alternative Reimbursement Dossier (Managed Entry Agreements)

Pharma and Medical device Companies apply to Alternative reimbursement Committee in order to accelerate reimbursement and access of products. In this context;

• Risk Sharing Models are generated (financial based and performance based models)